Detalles de la búsqueda
1.
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.
Clin Exp Dermatol;
48(8): 881-888, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37032446
2.
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
Br J Dermatol;
187(3): 338-352, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484697
3.
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021.
Allergol Int;
71(4): 448-458, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36064654
4.
Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis.
Int J Mol Sci;
22(4)2021 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33670758
5.
Differences Between Patient-Reported Versus Clinician-Observed Nonulcerative Signs and Symptoms of the Foot in Patients With Diabetes Mellitus.
J Wound Ostomy Continence Nurs;
46(2): 113-116, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30747799
6.
The Association between Tinea Pedis and Feet-Washing Behavior in Patients with Diabetes: A Cross-sectional Study.
Adv Skin Wound Care;
30(11): 510-516, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29049259
7.
Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635 nm.
Lasers Surg Med;
48(1): 30-5, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26462982
8.
A case of concurrent intercellular IgA dermatosis and linear IgA/IgG bullous dermatosis.
Australas J Dermatol;
61(3): e368-e369, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32114716
9.
Relationship between activity of daily living and asteatosis in the lower legs among elderly residents in long-term care institutions: a cross-sectional study.
Int Wound J;
12(5): 586-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24131671
10.
Treatment of skin laxity using multisource, phase-controlled radiofrequency in Asians: visualized 3-dimensional skin tightening results and increase in elastin density shown through histologic investigation.
Dermatol Surg;
40(7): 756-62, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25111348
11.
Authors' Response to a Letter to the Editor Re: Differences Between Patient-Reported Versus Clinician-Observed Nonulcerative Signs and Symptoms of the Foot in Patients With Diabetes Mellitus. J Wound Ostomy Continence Nurs. 2019;46(2): Differences Between Patient-Reported Versus Clinician-Observed Nonulcerative Signs and Symptoms of the Foot in Patients With Diabetes Mellitus.J Wound Ostomy Continence Nurs. 2019;46(2):113-116.
J Wound Ostomy Continence Nurs;
46(4): 283, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31274855
12.
Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial.
J Dermatol;
2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482989
13.
Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
J Dermatol;
51(4): 526-531, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279193
14.
Prevalence and risk factors for onychomycosis in acute care dermatology wards.
J Dermatol;
2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558466
15.
Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents.
J Dermatol;
50(8): 1014-1019, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37157898
16.
Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
J Dermatol;
50(5): 637-645, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539950
17.
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
J Dermatol;
50(1): e1-e19, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36412059
18.
English version of Japanese guidance for biologics in treating atopic dermatitis.
J Dermatol;
50(10): e311-e322, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650357
19.
Clinical study on the effects of the applied volume of moisturizer in patients with asteatosis.
J Dermatol;
49(1): 75-85, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34545613
20.
TERT/BMI1-transgenic human dermal papilla cells enhance murine hair follicle formation in vivo.
J Dermatol Sci;
106(2): 78-85, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440400